U.S. Markets closed

BIOLASE receives FDA clearance, CE Mark for EPIC 10 diode soft tissue laser

BIOLASE announced that it has received 510k clearance from the U.S. FDA and CE Mark approval for its EPIC 10 diode soft tissue laser. BIOLASE initiated commercial sales in the final days of the third quarter of 2012 throughout the European Union and in those Asian and Latin American countries that recognize the CE Mark. The company received notification of clearance from the FDA on Oct. 1, and immediately began offering the EPIC 10 for sale in the U.S.